ZBH

SEC source: 0001062993-21-004822 · form4.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,878.537

Underlying: Common Stock · 779.05 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-21-004822 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,317.437

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.421 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-004823 · form4.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,453.057

Underlying: Common Stock · 779.05 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-21-004823 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,088.616

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.383 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-004821 · form4.xml · derivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,220.16

Underlying: Common Stock · 779.05 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

SEC source: 0001062993-21-004821 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,062.207

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 16.724 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-004308 · form4.xml · nonDerivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,400

SEC source: 0001062993-21-004047 · form4.xml · derivative · entry 3

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 515

Underlying: Common Stock · 515 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: 515 of the RSUs vested on May 1, 2021. The remaining 515 RSUs will vest on May 1, 2022.

F3 · derivative.expiration_date: 515 of the RSUs vested on May 1, 2021. The remaining 515 RSUs will vest on May 1, 2022.

SEC source: 0001062993-21-004047 · form4.xml · nonDerivative · entry 2

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,098

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-004047 · form4.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-21-003427 · form4.xml · derivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,988

Underlying: Common Stock · 3,988 shares

Expires 2031-04-01

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on April 1, 2022.

SEC source: 0001062993-21-003341 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626.258

Underlying: Common Stock · 169.785 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.299 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003340 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84.893

Underlying: Common Stock · 84.893 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-21-003338 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,128.923

Underlying: Common Stock · 84.893 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.034 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003337 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,249.107

Underlying: Common Stock · 169.785 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 84.893 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: 84.893 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 4.502 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003336 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,154.838

Underlying: Common Stock · 200.655 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 39.971 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003335 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,553.568

Underlying: Common Stock · 208.372 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 32.802 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003334 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,577.233

Underlying: Common Stock · 169.785 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 12.776 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003332 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,799.016

Underlying: Common Stock · 192.937 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 20.810 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003333 · form4.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,743.19

Underlying: Common Stock · 169.785 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 17.692 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-003331 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,545.483

Underlying: Common Stock · 192.937 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.864 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001062993-21-002187 · form4.xml · derivative · entry 2

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 338 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002187 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 58 shares acquired under the Zimmer Biomet Holdings, Inc. (the ???Company???) Employee Stock Purchase Plan and pursuant to dividend reinvestment between August 4, 2020 and February 2, 2021.

SEC source: 0001062993-21-002186 · form4.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002186 · form4.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,402

F2 · balance_after: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-002186 · form4.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 56 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on January 9, 2021.

SEC source: 0001062993-21-002185 · form4.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002185 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,152

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-002185 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 134 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan and pursuant to dividend reinvestment between October 28, 2020 and January 27, 2021.

SEC source: 0001062993-21-002184 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,866 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F4 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002184 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,686

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-002184 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 209 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan on January 9, 2021.

SEC source: 0001062993-21-002183 · form4.xml · derivative · entry 3

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002183 · form4.xml · nonDerivative · entry 2

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,745

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-002183 · form4.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-21-002182 · form4.xml · derivative · entry 2

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 315 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Earned RSUs vested on February 26, 2021.

F2 · derivative.expiration_date: Earned RSUs vested on February 26, 2021.

SEC source: 0001062993-21-002182 · form4.xml · nonDerivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-21-002096 · form4.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,305

Underlying: Common Stock · 24,305 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002095 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,914

Underlying: Common Stock · 33,914 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002093 · form4.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,044

Underlying: Common Stock · 22,044 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002094 · form4.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,175

Underlying: Common Stock · 36,175 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002092 · form4.xml · derivative · entry 1

Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,088

Underlying: Common Stock · 5,088 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002090 · form4.xml · derivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,479

Underlying: Common Stock · 8,479 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002091 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,698

Underlying: Common Stock · 131,698 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-002089 · form4.xml · derivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,749

Underlying: Common Stock · 17,749 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0001062993-21-001862 · form4.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338

Underlying: Common Stock · 338 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs.

SEC source: 0001062993-21-001861 · form4.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 517

Underlying: Common Stock · 517 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 517 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 517 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 517 RSUs.

SEC source: 0001062993-21-001860 · form4.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310

Underlying: Common Stock · 310 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 310 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 310 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 310 RSUs.

SEC source: 0001062993-21-001859 · form4.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,866

Underlying: Common Stock · 1,866 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 1,866 RSUs.

SEC source: 0001062993-21-001858 · form4.xml · derivative · entry 1

Ellingson Rachel · CIK 0001557271 · SVP & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156

Underlying: Common Stock · 156 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 156 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 156 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 156 RSUs.